Cartesian Therapeutics Inc (RNAC)
Equity Ratio
-39.30%
Quarterly · Period ending:
RNAC Equity Ratio
Latest reported-39.30%period ending
Latest reported-39.30%period ending
RNAC Quarterly Equity Ratio (-272.03% → -39.30%)
Latest values, visible window
High-resolution chart · PNG
RNAC equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| -39.3016% | |
| -51.3601% | |
| -42.5895% | |
| -9.618% | |
| -0.6498% | |
| -5.3257% | |
| -1.5636% | |
| 0.1652% | |
| -29.1766% | |
| -35.9156% | |
| -144.299% | |
| 56.8959% | |
| 46.9141% | |
| 47.9013% | |
| 56.5617% | |
| 47.6297% | |
| 47.6455% | |
| 38.2742% | |
| 14.0859% | |
| -11.2053% | |
| -2.3388% | |
| -11.073% | |
| -10.884% | |
| -4.0785% | |
| -17.355% | |
| -9.8682% | |
| 8.4333% | |
| -12.4292% | |
| 0.1193% | |
| 23.7172% | |
| -12.1802% | |
| 16.5774% | |
| 33.0378% | |
| 46.2346% | |
| 51.2502% | |
| 59.3094% | |
| 66.8079% | |
| 55.6353% | |
| 61.5413% | |
| 76.2926% | |
| 75.3157% | |
| 41.304% | |
| -272.0274% |